NASDAQ:SLSN Solesence (SLSN) Stock Price, News & Analysis $0.80 -0.02 (-2.35%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$0.82 +0.02 (+2.66%) As of 09/18/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Solesence Stock (NASDAQ:SLSN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Solesence alerts:Sign Up Key Stats Today's Range$0.80▼$0.9750-Day Range$0.64▼$1.0752-Week Range$0.61▼$4.55Volume27,801 shsAverage Volume15,980 shsMarket Capitalization$56.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Solesence, Inc. is a skincare company focused on developing and commercializing science-based products designed to improve the health and appearance of skin. The company combines dermatological research, cosmetic formulation and biotechnology to create products intended to address concerns such as sun damage, uneven skin tone, visible signs of aging and other common skin conditions. Its portfolio includes topical skincare and sun-protection products formulated for daily use and professional skincare routines. Solesence develops products for physician, dermatology, aesthetic and consumer channels, with an emphasis on clinically informed formulations and skin-health benefits. The company works with skincare professionals and commercial partners to bring its products to market. Publicly available information about Solesence’s leadership, operating history and geographic reach is limited.AI Generated. May Contain Errors. Read More Solesence Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScoreSLSN MarketRank™: Solesence scored higher than 3% of companies evaluated by MarketBeat, and ranked 171st out of 171 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingSolesence has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageSolesence has only been the subject of 1 research reports in the past 90 days.Read more about Solesence's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Solesence is -26.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Solesence is -26.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSolesence has a P/B Ratio of 3.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted0.55% of the float of Solesence has been sold short.Short Interest Ratio / Days to CoverSolesence has a short interest ratio ("days to cover") of 23.72, which indicates bearish sentiment.Change versus previous monthShort interest in Solesence has recently decreased by 2.45%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolesence does not currently pay a dividend.Dividend GrowthSolesence does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest1 people have searched for SLSN on MarketBeat in the last 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Solesence insiders have not sold or bought any company stock.Percentage Held by Insiders4.80% of the stock of Solesence is held by insiders.Percentage Held by Institutions70.22% of the stock of Solesence is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Solesence's insider trading history. Receive SLSN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solesence and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SLSN Stock News HeadlinesSolesence, Inc. Charts Rebound Amid Mixed EarningsAugust 29, 2026 | tipranks.comSolesence, Inc. (SLSN) Q2 2026 Earnings Call TranscriptAugust 19, 2026 | seekingalpha.comThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.September 19 at 1:00 AM | Porter & Company (Ad)Solesence, Inc. (SLSN) Releases Q2 2026 Earnings: Revenue Falls 24.7% and Posts Net LossAugust 19, 2026 | quiverquant.comQSolésence Reports Second Quarter 2026 Financial ResultsAugust 19, 2026 | globenewswire.comSolésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11July 28, 2026 | globenewswire.comSolésence Brings Patent-Backed Skin Health Innovation to Hair and ScalpJuly 13, 2026 | globenewswire.comSolésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation AwardsJune 18, 2026 | globenewswire.comSee More Headlines SLSN Stock Analysis - Frequently Asked Questions How have SLSN shares performed this year? Solesence's stock was trading at $1.5950 at the beginning of 2026. Since then, SLSN shares have decreased by 49.6% and is now trading at $0.8036. How were Solesence's earnings last quarter? Solesence, Inc. (NASDAQ:SLSN) announced its quarterly earnings results on Thursday, November, 13th. The company reported ($0.02) earnings per share for the quarter. The company earned $14.60 million during the quarter. Solesence had a negative net margin of 3.40% and a negative trailing twelve-month return on equity of 11.58%. Who are Solesence's major shareholders? Solesence's top institutional shareholders include BlackRock Inc. (0.66%), Bank of New York Mellon Corp (0.45%) and Susquehanna International Group LLP (0.16%). Insiders that own company stock include R Janet Whitmore and Kevin Cureton. View institutional ownership trends. How do I buy shares of Solesence? Shares of SLSN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/13/2025Today9/19/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Personal Care Products Sub-IndustryPersonal Care Products Current SymbolNASDAQ:SLSN Previous SymbolNASDAQ:SLSN CIK883107 Webwww.solesence.com Phone(630) 771-6078Fax630-771-0825Employees115Year Founded1989Profitability EPS (Trailing Twelve Months)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$1.79 million Net Margins-3.40% Pretax Margin-4.99% Return on Equity-11.58% Return on Assets-3.79% Debt Debt-to-Equity RatioN/A Current Ratio0.97 Quick Ratio0.47 Sales & Book Value Annual Sales$62.06 million Price / Sales0.91 Cash Flow$0.04 per share Price / Cash Flow21.60 Book Value$0.25 per share Price / Book3.21Miscellaneous Outstanding Shares70,650,000Free Float67,256,000Market Cap$56.77 million OptionableN/A Beta1.27 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:SLSN) was last updated on 9/19/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solesence, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solesence With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
